FDA Tentative Approval: TALTZ — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

The FDA issued tentative approval for a supplemental application for TALTZ (ixekizumab) by Eli Lilly, indicating the submission is approvable under tentative ap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Non-radiographic Axial Spondyloarthritis
• Plaque Psoriasis
• Psoriatic Arthritis

Drugs mentioned

• TALTZ (IXEKIZUMAB)

Snippet

SUPPL TA for TALTZ (IXEKIZUMAB)